New Drug Cuts Tourette Tics in Half Without Side Effects
A breakthrough medication could become the first FDA-approved treatment designed specifically for children with Tourette syndrome, reducing tics by 50% without the harsh side effects of current drugs. After a successful Phase III trial across 77 sites, the drug ecopipam is heading for FDA review.
